Sealantium Medical
PrivateLast Round
Grant
Apr 4, 2020
Est. Valuation
$30.3M
Total Funding Raised
$1.51M
Company Overview
Sealantium Medical operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in April 2020.
Sealantium Medical is a biosurgery company that develops proprietary next-generation tissue sealants and hemostatic agents for patients undergoing surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sealantium Medical Comparables
Compare Sealantium Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AsparaGlue | 83% | |
| Cresilon | 78% | |
| Medcura, Inc. | 78% |
For institutional investors. Book with your work email.
Sealantium Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 4, 2020 | ||||
| Series B | Nov 14, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sealantium Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Biotech Alliances International | Series B |
| AVV Investment GmbH | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 43% MoM.
- May 18, 2026
Monthly visitors increased 173% MoM.
For institutional investors. Book with your work email.
Sealantium Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sealantium Medical's valuation, stock price, and market status.
Is Sealantium Medical a public or private company?
Sealantium Medical is a private company.
What is the current stock price of Sealantium Medical?
Sealantium Medical is a private company, so its shares have no public market price. Caplight tracks Sealantium Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sealantium Medical worth (valuation)?
Sealantium Medical's valuation is estimated at $30.3M based on funding round data.
Can I buy Sealantium Medical stock?
Sealantium Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sealantium Medical's last funding round?
Sealantium Medical's most recent funding round was Grant on April 4, 2020.
Who are the main investors in Sealantium Medical?
Key investors in Sealantium Medical include Biotech Alliances International, AVV Investment GmbH.
Will Sealantium Medical IPO soon?
No public IPO plans have been announced for Sealantium Medical.
How can I track Sealantium Medical secondary market activity?
Caplight tracks bids, offers, and trades in Sealantium Medical's shares on secondary markets.